Autoantibody Profiling in Lupus Patients using Synthetic Nucleic Acids

Area of Science:

• Immunology
• Molecular Biology
• Autoimmune Diseases

Background:

• Antinuclear antibodies (ANA), including anti-DNA (a-DNA) antibodies, are crucial for diagnosing autoimmune diseases like systemic lupus erythematosus (SLE).
• Current methods for measuring a-DNA titers lack precision and reproducibility due to the heterogeneity of natural DNA sources.

Purpose of the Study:

• To design and validate synthetic nucleic acid molecules as standardized antigens for a-DNA antibody detection.
• To improve the accuracy and reproducibility of a-DNA titer measurements.
• To explore novel clinical correlations and antibody-antigen interactions in SLE patients.

Main Methods:

• Development of a panel of synthetic nucleic acid molecules using native deoxyribonucleotide units.
• Enzyme-Linked Immunosorbent Assay (ELISA) utilizing synthetic antigens for a-DNA antibody detection.
• Application of ELISA tests in serological studies of pediatric and adult SLE cohorts.
• Computational analyses to investigate antibody-antigen recognition patterns.

Main Results:

• ELISA assays with synthetic antigens demonstrated high specificity and reproducibility.
• Novel clinical correlations were identified in pediatric and adult SLE patients.
• A specific synthetic antigen was preferentially recognized by antibodies in SLE sera.
• Computational analysis provided structural insights into antibody-DNA antigen interactions.

Conclusions:

• Synthetic nucleic acid molecules offer a standardized and reproducible platform for a-DNA antibody assays.
• This approach enhances diagnostic capabilities and facilitates deeper understanding of autoimmune disease mechanisms.
• The findings pave the way for improved development of DNA-based antigens for autoimmune diagnostics.